Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital

Houman Khalili, Rajeev Singh, Michael Wood, Anthony G Edwards, Mark Cooper, Colby Ayers, Elizabeth Moss, Jarett D Berry, Wanpen Vongpatanasin, James A de Lemos, Sandeep R Das

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with

Original languageEnglish (US)
Pages (from-to)522-525
Number of pages4
JournalAmerican Journal of Cardiology
Volume117
Issue number4
DOIs
StatePublished - Feb 15 2016

Fingerprint

clopidogrel
Safety-net Providers
Drug-Eluting Stents
Stents
Thrombosis
Myocardial Infarction
Health

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital. / Khalili, Houman; Singh, Rajeev; Wood, Michael; Edwards, Anthony G; Cooper, Mark; Ayers, Colby; Moss, Elizabeth; Berry, Jarett D; Vongpatanasin, Wanpen; de Lemos, James A; Das, Sandeep R.

In: American Journal of Cardiology, Vol. 117, No. 4, 15.02.2016, p. 522-525.

Research output: Contribution to journalArticle

@article{bedb30952ac44366adbf5b849abffd3e,
title = "Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital",
abstract = "Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with",
author = "Houman Khalili and Rajeev Singh and Michael Wood and Edwards, {Anthony G} and Mark Cooper and Colby Ayers and Elizabeth Moss and Berry, {Jarett D} and Wanpen Vongpatanasin and {de Lemos}, {James A} and Das, {Sandeep R}",
year = "2016",
month = "2",
day = "15",
doi = "10.1016/j.amjcard.2015.11.037",
language = "English (US)",
volume = "117",
pages = "522--525",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital

AU - Khalili, Houman

AU - Singh, Rajeev

AU - Wood, Michael

AU - Edwards, Anthony G

AU - Cooper, Mark

AU - Ayers, Colby

AU - Moss, Elizabeth

AU - Berry, Jarett D

AU - Vongpatanasin, Wanpen

AU - de Lemos, James A

AU - Das, Sandeep R

PY - 2016/2/15

Y1 - 2016/2/15

N2 - Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with

AB - Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with

UR - http://www.scopus.com/inward/record.url?scp=84958836276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958836276&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2015.11.037

DO - 10.1016/j.amjcard.2015.11.037

M3 - Article

C2 - 26721655

AN - SCOPUS:84958836276

VL - 117

SP - 522

EP - 525

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -